Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Marchioli

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Giornale Italiano Di Cardiologia|June 9, 1998
[Primary and secondary prevention of ischemic cardiopathy. A meta-analysis with meta-regression as a biologic mechanism: reflections on clinical practice based on scientific evidence]R Marchioli, R M Marfisi
Lancet (London, England)|February 17, 1996
Sheffield risk and treatment table for cholesterol lowering in prevention of coronary heart disease. GISSI-Prevenzione InvestigatorsR Marchioli, E Bomba, G Tognoni
Thrombosis and Haemostasis|July 1, 1997
Mechanisms of bleeding and thrombosis in myeloproliferative disordersR Landolfi, R Marchioli, C Patrono
Clinical Trials and Meta-Analysis|March 9, 1994
From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disordersR Di Mascio, R Marchioli, G Tognoni
Cerebrovascular Diseases (Basel, Switzerland)|February 25, 2000
Cholesterol reduction and stroke occurrence: an overview of randomized clinical trialsR Di Mascio, R Marchioli, G Tognoni
Clinical Trials and Meta-Analysis|September 5, 1994
Surrogate end-points: the case of trials on coronary atherosclerotic plaque regressionR Marchioli, J C Prieto, G Tognoni
Leukemia & Lymphoma|September 1, 1996
Feasibility of randomised clinical trials in rare diseases: the case of polycythemia veraR Marchioli, R Landolfi, T Barbui, et al.
Lancet (London, England)|August 26, 1998
Hypertension Optimal Treatment (HOT) trialF Avanzini, R Marchioli, C Alli, et al.
Lipids|February 12, 2002
Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto MiocardicoR Marchioli, C Schweiger, L Tavazzi, et al.
Lipids|February 12, 2002
n-3 polyunsaturated fatty acids and cardiovascular diseasesA Nordøy, R Marchioli, H Arnesen, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Giornale Italiano Di Cardiologia|June 9, 1998
[Primary and secondary prevention of ischemic cardiopathy. A meta-analysis with meta-regression as a biologic mechanism: reflections on clinical practice based on scientific evidence]R Marchioli, R M Marfisi
Lancet (London, England)|February 17, 1996
Sheffield risk and treatment table for cholesterol lowering in prevention of coronary heart disease. GISSI-Prevenzione InvestigatorsR Marchioli, E Bomba, G Tognoni
Thrombosis and Haemostasis|July 1, 1997
Mechanisms of bleeding and thrombosis in myeloproliferative disordersR Landolfi, R Marchioli, C Patrono
Clinical Trials and Meta-Analysis|March 9, 1994
From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disordersR Di Mascio, R Marchioli, G Tognoni
Cerebrovascular Diseases (Basel, Switzerland)|February 25, 2000
Cholesterol reduction and stroke occurrence: an overview of randomized clinical trialsR Di Mascio, R Marchioli, G Tognoni
Clinical Trials and Meta-Analysis|September 5, 1994
Surrogate end-points: the case of trials on coronary atherosclerotic plaque regressionR Marchioli, J C Prieto, G Tognoni
Leukemia & Lymphoma|September 1, 1996
Feasibility of randomised clinical trials in rare diseases: the case of polycythemia veraR Marchioli, R Landolfi, T Barbui, et al.
Lancet (London, England)|August 26, 1998
Hypertension Optimal Treatment (HOT) trialF Avanzini, R Marchioli, C Alli, et al.
Lipids|February 12, 2002
Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto MiocardicoR Marchioli, C Schweiger, L Tavazzi, et al.
Lipids|February 12, 2002
n-3 polyunsaturated fatty acids and cardiovascular diseasesA Nordøy, R Marchioli, H Arnesen, et al.
Pageof 6